Metraipolis › archive › dc_05eeafded5b1

Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma — Europe PMC PMID:41892825

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41892825
DOI
10.3390/medsci14010110
License (as archived)
solo-consultazione
Archived
2026-11-05T08:15:47.904Z
SHA-256 of the archived text
f4784dc6f9a55bca7587f49eb83ad0a3651a5addcaf69bd09075d599be28a98e
Stable URL of this page
https://metraipolis.com/documento/dc_05eeafded5b1

How to cite

Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma — Europe PMC PMID:41892825 — Europe PMC (en), https://europepmc.org/article/MED/41892825 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_05eeafded5b1 (Metraipolis archive dc_05eeafded5b1, sha256 f4784dc6f9a55bca7587f49eb83ad0a3651a5addcaf69bd09075d599be28a98e)
BibTeX
@misc{dc05eeafded5b1,
  title = {Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma — Europe PMC PMID:41892825},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41892825},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_05eeafded5b1; sha256 f4784dc6f9a55bca7587f49eb83ad0a3651a5addcaf69bd09075d599be28a98e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41892825. Agents can read the archived copy with the MCP tool read_document.